REPLIGEN CORP (RGEN) Total liabilities 2016–2025
REPLIGEN CORP (RGEN) total liabilities at each fiscal year-end, per SEC filings.
$843.6MFY2025 · since FY2016: $120.1M → $843.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $843.6M | -1.6% |
| FY2024 | $856.9M | -1.1% |
| FY2023 | $866.3M | +39.5% |
| FY2022 | $620.9M | +2.1% |
| FY2021 | $608.3M | +62.8% |
| FY2020 | $373.7M | +9.8% |
| FY2019 | $340.3M | +114.0% |
| FY2018 | $159.1M | +4.7% |
| FY2017 | $152.0M | +26.5% |
| FY2016 | $120.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More RGEN financial trends
RGEN RevenueRGEN Net incomeRGEN Net marginRGEN Gross profitRGEN Gross marginRGEN Operating incomeRGEN Operating marginRGEN Operating cash flowRGEN Free cash flowRGEN Capital expendituresRGEN Return on equityRGEN Stock buybacksRGEN Dividends paidRGEN Total assetsRGEN Shareholders’ equityRGEN overview →